1. Home
  2. RDHL vs LEDS Comparison

RDHL vs LEDS Comparison

Compare RDHL & LEDS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RDHL
  • LEDS
  • Stock Information
  • Founded
  • RDHL 2009
  • LEDS 2005
  • Country
  • RDHL Israel
  • LEDS Taiwan
  • Employees
  • RDHL N/A
  • LEDS N/A
  • Industry
  • RDHL Biotechnology: Pharmaceutical Preparations
  • LEDS Semiconductors
  • Sector
  • RDHL Health Care
  • LEDS Technology
  • Exchange
  • RDHL Nasdaq
  • LEDS Nasdaq
  • Market Cap
  • RDHL 8.6M
  • LEDS 9.4M
  • IPO Year
  • RDHL N/A
  • LEDS 2010
  • Fundamental
  • Price
  • RDHL $6.99
  • LEDS $1.38
  • Analyst Decision
  • RDHL
  • LEDS
  • Analyst Count
  • RDHL 0
  • LEDS 0
  • Target Price
  • RDHL N/A
  • LEDS N/A
  • AVG Volume (30 Days)
  • RDHL 21.2K
  • LEDS 79.0K
  • Earning Date
  • RDHL 12-27-2024
  • LEDS 01-10-2025
  • Dividend Yield
  • RDHL N/A
  • LEDS N/A
  • EPS Growth
  • RDHL N/A
  • LEDS N/A
  • EPS
  • RDHL N/A
  • LEDS N/A
  • Revenue
  • RDHL $3,707,000.00
  • LEDS $5,183,000.00
  • Revenue This Year
  • RDHL $224.90
  • LEDS N/A
  • Revenue Next Year
  • RDHL $82.69
  • LEDS N/A
  • P/E Ratio
  • RDHL N/A
  • LEDS N/A
  • Revenue Growth
  • RDHL N/A
  • LEDS N/A
  • 52 Week Low
  • RDHL $6.35
  • LEDS $0.92
  • 52 Week High
  • RDHL $43.50
  • LEDS $2.29
  • Technical
  • Relative Strength Index (RSI)
  • RDHL 42.91
  • LEDS 50.13
  • Support Level
  • RDHL $7.09
  • LEDS $1.21
  • Resistance Level
  • RDHL $7.44
  • LEDS $1.70
  • Average True Range (ATR)
  • RDHL 0.53
  • LEDS 0.12
  • MACD
  • RDHL -0.03
  • LEDS 0.01
  • Stochastic Oscillator
  • RDHL 12.36
  • LEDS 24.00

About RDHL Redhill Biopharma Ltd.

Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is focused primarily on the advancement of its development pipeline of clinical-stage therapeutic candidates. The company also commercializes in the U.S. GI-related products, Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). The company's current pipeline consists of five therapeutic candidates, which are Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, most of which are in clinical development.

About LEDS SemiLEDS Corporation

SemiLEDs Corp develops, manufactures, and sells light-emitting diode chips and LED components. The company's products include LED Chips, LED Components, and Lighting Products. Its products are used for general lighting applications, including street lights and commercial, industrial, system, and residential lighting; specialty industrial applications, such as ultraviolet, or Ultraviolet, curing of polymers, LED light therapy in medical/cosmetic applications, counterfeit detection, LED lighting for horticulture applications, architectural lighting and entertainment lighting. Substantial revenue is generated from the sale of LED components products. Geographically, it derives a majority of its revenue from Japan.

Share on Social Networks: